TABLE 2.
Pathologic characteristics and molecular test results in both patients
No. | Sample types | TTF1 (IHC) | Naspin A (IHC) | EGFR/KRAS mutations | ALK (IHC) | ALK (RT‐PCR) | ALK (FISH) | ALK (NGS) | Tumor percentage |
---|---|---|---|---|---|---|---|---|---|
P1 | LP | + | + | WT/WT | + | − | − (12%) | EML4‐ALK | 80 |
P2 | LP | + | + | WT/WT | + | − | + (20%) | PRKAR1A‐ALK | 40 |
Abbreviations: LB, lymph nodes biospy; LP, lung puncture; +, positive; −, negative.